In silico receptor-based drug design of X,Y-benzenesulfonamide derivatives as selective COX-2 inhibitors-Reference-Cited by-同舟云学术

In silico receptor-based drug design of X,Y-benzenesulfonamide derivatives as selective COX-2 inhibitors

Published:2017-02 Issue:2 Volume:20 Page:169-180
ISSN:1631-0748
Container-title:Comptes Rendus Chimie
language:en
Short-container-title:Comptes Rendus Chimie

Author:

Pérez David J.,Sarabia Orlando,Villanueva-García Manuel,Pineda-Urbina Kayim^ORCID,Ramos-Organillo Ángel,Gonzalez-Gonzalez Jorge,Gómez-Sandoval Zeferino,Razo-Hernández Rodrigo Said

Publisher

Elsevier BV

Subject

General Chemical Engineering,General Chemistry

Reference49 articles.

1. Cyclooxygenases: structural and functional insights

2. Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition

3. Structural and Functional Basis of Cyclooxygenase Inhibition

4. The 2′-Trifluoromethyl Analogue of Indomethacin Is a Potent and Selective COX-2 Inhibitor

5. Selective COX-2 inhibitors. Part 2: Synthesis and biological evaluation of 4-benzylideneamino- and 4-phenyliminomethyl-benzenesulfonamides

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel ciprofloxacin and norfloxacin-tetrazole hybrids as potential antibacterial and antiviral agents: Targeting S. aureus topoisomerase and SARS-CoV-2-MPro;Journal of Molecular Structure;2023-02

2. In Silico Studies of Lamiaceae Diterpenes with Bioinsecticide Potential against Aphis gossypii and Drosophila melanogaster;Molecules;2021-02-02

3. Synthesis, crystal structure, antibacterial, antiproliferative and QSAR studies of new bismuth(III) complexes of pyrrolidineditiocarbamate of dithia-bismolane and bismane, oxodithia- and trithia-bismocane;Journal of Molecular Structure;2020-10

4. Antiproliferative and antiinflammatory coxib–combretastatin hybrids suppress cell cycle progression and induce apoptosis of MCF7 breast cancer cells;Molecular Diversity;2020-06-30

5. Synthesis of 1,4-Biphenyl-triazole Derivatives as Possible 17β-HSD1 Inhibitors: An in Silico Study;ACS Omega;2020-06-01